ITC Begins Section 337 Investigation on Wearable Electroencephalogram Devices
The International Trade Commission began a Section 337 investigation on allegations that Natus Medical Inc. and its subsidiary Excel-Tech Ltd. are importing and selling wearable electroencephalogram devices that infringe patents held by Ceribell Inc. (ITC Inv. No. 337-TA-1458), it said in an Aug. 6 fact sheet.
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
Ceribell filed the complaint in July and is seeking a limited exclusion order and cease and desist orders against the respondents to bar from entry "certain wearable electroencephalogram devices and systems and components thereof" that violate the complainants' patents (see 2507090031). The company described its products as "a first-of-its-kind technology that integrates reliable highly portable hardware with proprietary AI-powered algorithms to deliver precise seizure detection and assessment in minutes rather than hours or days."